It has been found that the enhancement of the PI3K/AKT signaling pathway is one of the most common tumor sign alterations in breast cancer; more than 30% of invasive breast cancer involves PI3K/AKT mutation (Bachman et al., 2004). Here, AKT1 is linked to invasive breast carcinoma.